2020
DOI: 10.7897/2230-8407.110545
|View full text |Cite
|
Sign up to set email alerts
|

The Impact of Natural Compounds in the Fight Against Covid-19: A Review

Abstract: Over 200,000 lives have been claimed by Covid-19 all over the world. The impact of this disease has led the World Health Organization (WHO) to declare COVID-19 as a global disaster. Diverse precautions have been established to wipe out this disease and hence, prevent it from causing severe damages on earth. However, these precautions could not fully eradicate the disease since there is still a lack of a preventive vaccine or any antiviral treatments. Hence, there is a crucial need to find a platform where nove… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 22 publications
0
2
0
Order By: Relevance
“…However, cross-immunity alone cannot explain the low COVID-19 incidence in Africa, another important argument being the large-scale use of antimalarial drugs, which have anti-SARS-CoV-2 properties [21,22]. It seems that SARSCoV-2 (COVID-19 virus) behaves like HIV (human immuno-dependent virus) by attacking T-cells [23] and like Plasmodium spp by destroying haemoglobin, which causes hypoxia in the patient [24]. The disease is clinically characterised by coughing, dyspnoea or respiratory discomfort, etc.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…However, cross-immunity alone cannot explain the low COVID-19 incidence in Africa, another important argument being the large-scale use of antimalarial drugs, which have anti-SARS-CoV-2 properties [21,22]. It seems that SARSCoV-2 (COVID-19 virus) behaves like HIV (human immuno-dependent virus) by attacking T-cells [23] and like Plasmodium spp by destroying haemoglobin, which causes hypoxia in the patient [24]. The disease is clinically characterised by coughing, dyspnoea or respiratory discomfort, etc.…”
Section: Resultsmentioning
confidence: 99%
“…The disease is clinically characterised by coughing, dyspnoea or respiratory discomfort, etc. [24]. Thus, three criteria can be used to select medicinal plants of potential interest as a source of antiCOVID-19 agents.…”
Section: Resultsmentioning
confidence: 99%